Go Premium in Our Biggest Sale Ever

Go Ultimate 75% OFF

HK:3692 Stock Latest News

RatingsHansoh Pharma: Strong Oncology Platform and Expanding Pipeline Support Buy Rating and HKD46 Target1w ago

Company AnnouncementsHansoh Strikes Multibillion-Dollar ADC Pact With Roche to Expand Global Footprint3w ago3692
Company AnnouncementsHansoh’s Aumolertinib EU Application Validated by EMA1M ago3692
Company AnnouncementsHansoh Faces EU Setback on Aumolertinib but Vows Rapid Reapplication1M ago3692
Company AnnouncementsHansoh Pharma’s Osteosarcoma Biologic HS-20093 Accepted for Review by China’s NMPA1M ago3692

Hansoh’s Osteosarcoma Drug HS-20093 Wins NMPA Priority Review in China

Company AnnouncementsHansoh’s Osteosarcoma Drug HS-20093 Wins NMPA Priority Review in China1M ago3692

Company AnnouncementsHansoh Pharma’s TYK2 Psoriasis Drug Clears Key Phase III Trial Milestone1M ago3692

Company AnnouncementsHansoh Pharma Wins NMPA Nod for Clinical Trials of Innovative Cancer Drug HS-201971M ago3692

Company AnnouncementsHansoh’s Lung Cancer Drug HS-20093 Wins NMPA Priority Review2M ago3692
Company AnnouncementsHansoh Pharma’s HS-20093 ADC for Small Cell Lung Cancer Accepted by China’s NMPA2M ago3692
Company AnnouncementsHansoh boosts profit on innovative drugs as lung cancer portfolio wins EU and China approvals2M ago3692
Company AnnouncementsHansoh Pharmaceutical Declares Interim Dividend for First Half of 20262M ago3692

Analyst Reiterates Buy on Hansoh, Raising Target Price on Robust Innovative Drug Growth and Expanding Late-Stage Pipeline

RatingsAnalyst Reiterates Buy on Hansoh, Raising Target Price on Robust Innovative Drug Growth and Expanding Late-Stage Pipeline2M ago

Company AnnouncementsHansoh Pharma Wins NMPA Nod for Clinical Trials of New Cholesterol Drug3M ago3692

Company AnnouncementsHansoh Pharmaceutical Schedules Board Meeting to Approve Interim Results and Dividend3M ago3692

Company AnnouncementsHansoh’s Osteosarcoma Drug HS-20093 Hits Phase III Target, China Filing Planned3M ago3692
Market NewsWhy Is Penny Stock NextCure (NXTC) Up Today?4M agoNXTC
Company AnnouncementsHansoh Pharma Licenses IL-23 Drug to Avere and Gains Major Stake in Nasdaq-Bound Merger4M ago3692
Company AnnouncementsHansoh Pharma’s HS-20093 Meets Phase III Survival Goal in Small Cell Lung Cancer4M ago3692

Hansoh Pharma Wins NMPA Trial Approvals for New Metabolic Injection

Company AnnouncementsHansoh Pharma Wins NMPA Trial Approvals for New Metabolic Injection4M ago3692

Company AnnouncementsHansoh Pharmaceutical Shareholders Approve All Resolutions at 2026 AGM4M ago3692

Company AnnouncementsHansoh Pharma Wins NMPA Nod to Review New Injection for Kidney-Disease Complication5M ago3692